2nd Quarter - Report

PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION

Firm
Client
Income
—
Expenses
$281,444
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

All issues related to commercial drug coverage including pharmacy payment, reimbursement, competition and plan administration. Health information technology with respect to electronic prescribing of prescription drugs. Promotion of competition in theprescription drug marketplace including the drug approval process.

LobbyistCovered position, as disclosed
TIM W BROGAN —
JONATHAN M HEAFITZ —
ELLEN DUNBAR JENKINS —
GREG SCOTT JOHNSON —
BARBARA A LEVY —
MARK D MERRITT —
DANA L SHERWOOD —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); White House Office; SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

All issues related to drug coverage under Medicare/Medicaid including pharmacy payment, reimbursement, competition and plan administration. Electronic prescribing or prescription drugs.

LobbyistCovered position, as disclosed
TIM W BROGAN —
JONATHAN M HEAFITZ —
ELLEN DUNBAR JENKINS —
GREG SCOTT JOHNSON —
BARBARA A LEVY —
MARK D MERRITT —
DANA L SHERWOOD —

Contacted: SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.